China Medical Devices Market Size, Share & Industry Analysis, By Type (Orthopedic Devices, Cardiovascular Devices, Diagnostic Imaging, In-vitro Diagnostic (IVD), Minimally Invasive Surgery Devices (MIS), Wound Management, Diabetes Care Devices, Ophthalmic Devices, Dental Devices, Nephrology Devices, General Surgery, and Others), By End-user (Hospitals & ASC's, Clinics, and Others), and Country Forecast, 2025-2032

The China medical devices market size was valued at USD 40.31 billion in 2024. The market is projected to grow from USD 43.67 billion in 2025 to USD 82.02 billion by 2032, exhibiting a CAGR of 9.4% during the forecast period.

Medical devices refer to instruments, apparatus, machines, or implants used for medical purposes, including diagnosis, monitoring, treatment, and assisting disabled individuals. They are used to monitor bodily functions, restore and modify anatomical structures or physiological processes, and help in conception control.

The market is witnessing significant growth driven by technological advancements in medical devices, offering benefits such as better patient outcomes and streamlined clinical workflows. Moreover, the increasing number of surgical procedures due to growing medical complications in China is fueling demand for such advanced products. In response, key players are developing and launching new devices, contributing to higher product penetration over the forecast period.

The key players in the market include Medtronic, Johnson & Johnson Services, Inc., and GE Healthcare. These companies are focused on expanding their presence in China through new launches, collaborations, acquisitions, and increased investments. These initiatives are anticipated to help them gain a significant share of the China medical devices market in the forthcoming years.

MARKET DYNAMICS

Market Drivers

Increasing Number of Surgical Procedures to Fuel Market Expansion

Over the past few years, there has been a significant rise in surgical procedures in China, fueled by the growing prevalence of chronic diseases. These conditions often lead to medical complications that require surgical interventions. These surgical procedures are highly performed in orthopedics, cardiology, and oncology.

Additionally, lifestyle changes associated with urbanization have contributed to an increase in conditions such as obesity, diabetes, and cardiovascular disorders, which often require advanced diagnostic tools and surgical management procedures. This trend is propelling the demand for minimally invasive tools, robotic systems, and diagnostic imaging devices.

• For instance, according to the data published by the NCBI in November 2023, around 728 hospitals in China and Hong Kong performed 71,693 surgeries for congenital heart diseases in 2021.

Moreover, China’s expanding healthcare infrastructure and increasing health insurance coverage are further contributing to the higher utilization of such devices. The government's focus on improving healthcare access in rural areas is also leading to more surgeries in public and private healthcare settings.

In response, key players are developing cost-effective and technologically advanced solutions to support the high volume of surgical procedures, increasing product availability, and diversification. These factors are projected to fuel the China medical devices market growth in the forthcoming years.

Market Restraints

 High Cost of Medical Devices to Hamper Market Growth

Despite the high adoption of advanced medical technologies such as PET-CT scanners and robotic surgical tools in metropolitan regions such as Beijing, Shanghai, and Guangzhou, their high cost is limiting widespread adoption, particularly in lower-tier cities and rural healthcare facilities, where smaller hospitals and clinics often lack the financial capacity to invest in these technologies.

• For instance, according to an article published by Nanjing Perlove Medical Equipment Co., Ltd. in August 2023, the average product price of the Da Vinci system can cost around USD 3.2 million in China, not including training, maintenance, and operating costs.

This high initial investment is creating a difference in the quality of care between urban and rural settings and slowing the adoption rate across the country. Moreover, while domestic manufacturers are competitive on cost, they often face challenges in matching the quality and performance of products offered by established international brands. This is pushing hospitals to opt for expensive imported devices for reliability and precision, creating pressure for high investment and limited return on investment. Such a scenario is expected to hinder market growth during the forecast period.  

Market Opportunities

Rising Demand for Home Healthcare and Wearable Devices to Offer Lucrative Opportunity

In recent years, the increasing prevalence of chronic diseases, coupled with an aging population, has shifted focus toward long-term care and self-monitoring solutions in China. For instance, according to data published by the NCBI in August 2024, China has experienced a rapid surge in home care due to its aging population. This trend is expected to present significant opportunities for key players in home healthcare and wearable devices to increase the availability of devices such as ECG monitors, glucose meters, smart thermometers, and fitness trackers.

Moreover, individuals in China are becoming increasingly health-conscious, thereby driving demand for remote monitoring solutions, such as blood pressure monitors and pulse oximeters. Additionally, in the past years, the COVID-19 pandemic further accelerated this shift, which has fueled the utilization of at-home diagnostics. In response, domestic companies are entering the market, offering opportunities for partnerships and acquisitions. Additionally, established players are focusing on expanding their distribution network and launching user-friendly and affordable products, which is contributing to high product penetration. These developments are anticipated to provide companies with a competitive advantage and lucrative opportunities for market expansion.

Market Challenges

Regulatory Complexity and Prolonged Approval Timelines to Limit Market Growth

Despite the government's efforts to streamline the approval process, complex regulatory frameworks remain a major challenge for both domestic and international medical device manufacturers in China. The National Medical Products Administration (NMPA) requires multi-tiered clinical evaluation, technical review, and testing, which often results in delayed market entry, especially for Class II and Class III devices.

• For instance, according to the article published by the NCBI in March 2025, all medical devices must obtain product and manufacturing licenses in China before they are marketed. Class I medical devices are filed with the NMPA at the municipal level, while Class II requires registration and approval by provincial NMPA representatives. Class III and imported medical devices must undergo registration and approval by the central NMPA, and international manufacturers are additionally required to establish a China-based legal entity for registration.

Unlike the U.S. FDA or other international regulatory frameworks, China's approval process is frequently subject to policy changes, which can disrupt commercialization plans for global manufacturers. These factors are expected to challenge the adoption of advanced medical devices, thereby hampering market growth.

Medical Devices Market Trends

Integration of Artificial Intelligence (AI) in Diagnostics and Imaging to Emerge as a Key Trend

Currently, there is an increasing adoption of artificial intelligence (AI) in diagnostics and imaging devices in China due to a shifting preference toward healthcare digitization. This trend is supported by the country’s established healthcare infrastructure and higher spending on advanced technologies.  AI is playing a transformative role, particularly in radiology and other diagnostic imaging fields, automating processes, enhancing accuracy, and streamlining workflows in healthcare settings. As a result, key players are investing heavily in AI-driven medical technologies, which is expected to foster innovation and approvals for such tools.

• For instance, according to the data published by the National Center for Biotechnology Information (NCBI) in September 2024, China’s government database identified 59 AI medical devices approved in the country as of July 2023.

AI-based diagnostic systems are now capable of detecting early signs of diseases such as lung cancer and diabetic retinopathy with higher accuracy and speed, leading to growing adoption of AI-enabled imaging solutions in hospitals across China.

Additionally, healthcare organizations and training institutions are conducting training programs on AI-enabled diagnostic imaging, which is expected to further increase adoption and reshape the diagnostic landscape in China.

Download Free sample to learn more about this report.

Segmentation Analysis

By Type

In-vitro Diagnostics (IVD) Segment Dominated the Market Due to Growing Prevalence of Infectious and Chronic Diseases

Based on type, the market is segmented into orthopedic devices, cardiovascular devices, diagnostic imaging, in-vitro diagnostic (IVD), minimally invasive surgery devices (MIS), wound management, diabetes care devices, ophthalmic devices, dental devices, nephrology devices, general surgery, and others.

The in-vitro diagnostic (IVD) segment held the largest China medical devices market share in 2024, attributed to the growing prevalence of infectious diseases such as HIV, hepatitis, and others. This is increasing the number of in-vitro diagnostics (IVDs) across various settings, including clinical laboratories, hospitals, and even at home in China. In response, key players are expanding their distribution networks for in-vitro diagnostics in the country, thereby increasing device penetration.

The diabetes care segment held a significant share of the China market in 2024. Its growth is attributed to increasing demand for at-home monitoring devices such as blood glucose meters. With China having the highest number of diabetes cases globally, the demand for home-based monitoring and treatment devices is surging, prompting key players to introduce more products tailored to this need.

• For instance, according to the data published by the International Diabetes Federation (IDF), there were 147,981,200 cases of diabetes or 11.9% prevalence among adults in China in 2024.

To know how our report can help streamline your business, Speak to Analyst

By End-user

Hospitals & ASCs Segment Dominated Due to Higher Patient Visits to These Settings

Based on end-user, the market is segmented into hospitals & clinics, pharmaceutical & medical device manufacturers, and others.

The hospitals & ASCs segment held a dominant share in 2024, attributed to higher patient visits to these settings due to the well-equipped intensive care units, operation theaters, and other facilities. These settings offer multiple services under one roof, providing better accessibility, discounts, and time-saving for patients. Moreover, the expansion of international hospitals in China is also expected to spur advanced medical device requirements in these settings.

• For instance, in September 2024, China announced plans to allow the establishment of wholly foreign-owned hospitals in nine regions of the country.

The clinics segment held the second-largest China market share in 2024. This growth is attributed to an increasing number of neurology clinics, diabetes clinics, and others, which is driving the demand for diagnostic and treatment devices. This presents lucrative opportunities for key players to expand their presence in the market.  

COMPETITIVE LANDSCAPE

Key Market Players

Key Firms Focus on Technological Advancements to Boost their Market Share

The China medical devices market witnesses a fragmented structure, with several players such as Medtronic, Johnson & Johnson Services, Inc., and GE Healthcare accounting for a major share in 2024. This dominance is attributed to their strong focus on introducing technologically advanced devices to support a wider range of applications in healthcare facilities.

Other major players in the market include Abbott, Koninklijke Philips N.V., Siemens Healthineers AG, and BD. These companies are strengthening their presence in China through collaborations, partnerships, and increasing investment aimed at securing product approvals. Such initiatives are expected to enhance their market share during the forecast period.

LIST OF KEY MEDICAL DEVICES COMPANIES PROFILED

• Medtronic (Ireland)
• Johnson & Johnson Services, Inc. (U.S.)
• Koninklijke Philips N.V (Netherlands)
• Hoffmann-La Roche Ltd (Switzerland)
• Boston Scientific Corporation (U.S.)
• Fresenius Medical Care AG (Germany)
• GE Healthcare (U.S.)
• Siemens Healthineers AG (Germany)
• Stryker (U.S.)
• Abbott (U.S.)
• BD (U.S.)

KEY INDUSTRY DEVELOPMENTS

• July 2025 – Ypsomed received NMPA approval for Maxdutide, a first-in-class dual glucagon (GCG)/glucagon-like peptide-1 (GLP-1) receptor agonist, which is delivered using a YpsoMate 1.0 auto-injector.
• May 2024 – Medtronic received the National Medical Products Administration (NMPA) approval for Symplicity Spyral, a renal denervation (RDN) system in China, to sell the system to hospitals commercially.
• October 2023 – Boston Scientific Corporation announced its plan to establish its first China-based manufacturing site in Shanghai, expanding its footprint in China.
• January 2022 – MicroPort Scientific Corporation received NMPA approval for the Toumai SP laparoscopic surgical robot for operating rooms with limited space in China.
• November 2021 – GE Healthcare launched the fifth-generation Fortis series of whole-body ultrasound products at its Wuxi base in China.

REPORT COVERAGE

The research report provides a detailed market analysis and focuses on leading companies, competitive landscape, type, and end-user. Additionally, it offers insights into market dynamics and market trends. The report also highlights key industry developments and new product launches. In addition, it consists of several factors that have contributed to the market's growth over the past few years.

To gain extensive insights into the market, Download for Customization

Report Scope & Segmentation